Literature DB >> 9259591

Soluble factor(s) produced by adult bone marrow stroma inhibit in vitro proliferation and differentiation of fetal liver BFU-E by inducing apoptosis.

V Roy1, C M Verfaillie.   

Abstract

Hematopoiesis occurs in different organs during fetal development. Several studies suggest that the growth of hematopoietic progenitors at one stage of ontogenic maturation may not be supported by a microenvironment from a different ontogenic stage. To determine if human fetal liver (FL) clonogenic progenitors can develop in an adult bone marrow (ABM) microenvironment, we compared growth of BFU-E and CFU-GM from 7-14-wk-old FL, 11-20-wk-old fetal bone marrow (FBM), umbilical cord blood (UCB), or ABM in clonogenic medium with or without ABM stroma. In contrast to BFU-E from FBM, UCB, or ABM, soluble factor(s) produced by ABM stroma severely suppressed growth of 98% of FL BFU-E by inducing apoptosis of cells beyond early erythroblast stage. The nature of the soluble factor remains unknown, although we have evidence that it is heat labile with molecular mass < 10 kD. Antibody neutralization studies indicate that TGF-beta1, IL-1, TNF-alpha, macrophage inflammatory protein (MIP)-1alpha, or IFN-gamma are not responsible. The observation that FL progenitors may not be capable of differentiating when transferred to an ABM microenvironment may have important implications for FL transplantation into postnatal recipients. Further, this demonstrates that ontogenic stage-specific interactions between hematopoietic progenitors and their microenvironment are important for the normal development of hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259591      PMCID: PMC508264          DOI: 10.1172/JCI119607

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis.

Authors:  C M Verfaillie
Journal:  Blood       Date:  1992-06-01       Impact factor: 22.113

2.  Erythropoiesis is distinct at each stage of ontogeny.

Authors:  R S Weinberg; L Y He; B P Alter
Journal:  Pediatr Res       Date:  1992-02       Impact factor: 3.756

Review 3.  Embryonic and fetal hemopoiesis: an overview.

Authors:  M Tavassoli
Journal:  Blood Cells       Date:  1991

4.  Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin.

Authors:  T Papayannopoulou; B Nakamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

5.  Liver-derived fetal hematopoietic stem cells selectively and preferentially home to the fetal bone marrow.

Authors:  E D Zanjani; J L Ascensao; M Tavassoli
Journal:  Blood       Date:  1993-01-15       Impact factor: 22.113

6.  Identification and characterization of three classes of erythroid progenitors in human fetal liver.

Authors:  C Peschle; A R Migliaccio; G Migliaccio; R Ciccariello; F Lettieri; S Quattrin; G Russo; G Mastroberardino
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

7.  The fetus as an optimal donor and recipient of hemopoietic stem cells.

Authors:  E D Zanjani; J L Ascensao; A W Flake; M R Harrison; M Tavassoli
Journal:  Bone Marrow Transplant       Date:  1992       Impact factor: 5.483

8.  In utero transplantation of stem cells in humans: immunological aspects and clinical follow-up of patients.

Authors:  J L Touraine; D Raudrant; A Rebaud; M G Roncarolo; S Laplace; L Gebuhrer; H Betuel; D Frappaz; F Freycon; M T Zabot
Journal:  Bone Marrow Transplant       Date:  1992       Impact factor: 5.483

9.  Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero.

Authors:  E D Zanjani; M G Pallavicini; J L Ascensao; A W Flake; R G Langlois; M Reitsma; F R MacKintosh; D Stutes; M R Harrison; M Tavassoli
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

Review 10.  Fetal liver transplantation: biology and clinical results.

Authors:  J L Touraine; M G Roncarolo; R Bacchetta; D Raudrant; A Rebaud; S Laplace; P Cesbron; L Gebuhrer; M T Zabot; F Touraine
Journal:  Bone Marrow Transplant       Date:  1993       Impact factor: 5.483

View more
  4 in total

1.  Cell cycle status of CD34+ cells in human fetal bone marrow.

Authors:  J M Koenig; B Luttge; N A Benson; R D Christensen
Journal:  Early Hum Dev       Date:  2001-12       Impact factor: 2.079

2.  Expansion of CD34+ cells on telomerized human stromal cells without losing erythroid-differentiation potential in a serum-free condition.

Authors:  Masayoshi Kobune; Yutaka Kawano; Junji Kato; Yoshinori Ito; Hiroki Chiba; Kiminori Nakamura; Akihito Fujimi; Takuya Matsunaga; Hirofumi Hamada; Yoshiro Niitsu
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

3.  Capture and printing of fixed stromal cell membranes for bioactive display on PDMS surfaces.

Authors:  Jungwoo Lee; Jennifer B Wang; Francesca Bersani; Biju Parekkadan
Journal:  Langmuir       Date:  2013-08-12       Impact factor: 3.882

4.  The significance of membrane fluidity of feeder cell-derived substrates for maintenance of iPS cell stemness.

Authors:  Yue Zhou; Hongli Mao; Binata Joddar; Nobuhisa Umeki; Yasushi Sako; Ken-Ichi Wada; Chieko Nishioka; Eiki Takahashi; Yi Wang; Yoshihiro Ito
Journal:  Sci Rep       Date:  2015-06-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.